{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:27:01Z","timestamp":1758709621583},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4511,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ymthe.2004.03.016","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T09:50:20Z","timestamp":1083405020000},"page":"804-817","source":"Crossref","is-referenced-by-count":24,"title":["A Conditionally Replicating Adenovirus for Nasopharyngeal Carcinoma Gene Therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Marie C","family":"Chia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolly","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Busson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J","family":"Klamut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.03.016_BIB1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0167-8140(02)00132-9","article-title":"Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study\u2014is combined modality treatment really necessary?","volume":"63","author":"Chow","year":"2002","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/oxfordjournals.epirev.a036130","article-title":"Etiology of nasopharyngeal carcinoma\u2014a review","volume":"15","author":"Hildesheim","year":"1993","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein\u2013Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1044579X02000901","article-title":"The significance of LMP1 expression in nasopharyngeal carcinoma","volume":"12","author":"Tsao","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","article-title":"EBNA-1: a protein pivotal to latent infection by Epstein\u2013Barr virus","volume":"10","author":"Leight","year":"2000","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(00)81056-9","article-title":"Crystal structure of the DNA-binding domain of the Epstein\u2013Barr virus origin-binding protein, EBNA1, bound to DNA","volume":"84","author":"Bochkarev","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB7","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1128\/JVI.72.7.6181-6185.1998","article-title":"Up to 100-fold increase of apparent gene expression in the presence of Epstein\u2013Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids","volume":"72","author":"Langle-Rouault","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/10430340050015932","article-title":"Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector","volume":"11","author":"Kaneda","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB9","first-page":"171","article-title":"Tumor-targeted gene therapy for nasopharyngeal carcinoma","volume":"62","author":"Li","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/viro.1998.9293","article-title":"Trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus","volume":"248","author":"Goldsmith","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/89901","article-title":"Replication-selective virotherapy for cancer: biological principles, risk management and future directions","volume":"7","author":"Kirn","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB12","first-page":"507","article-title":"Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines","volume":"3","author":"Li","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0360-3016(98)00432-5","article-title":"The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma","volume":"43","author":"Li","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0167-8140(01)00398-X","article-title":"Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts","volume":"61","author":"Lax","year":"2001","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0042-6822(88)90302-9","article-title":"A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5","volume":"163","author":"McGrory","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1073\/pnas.81.7.1991","article-title":"Genomic sequencing","volume":"81","author":"Church","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T) (\u2212\u0394\u0394C) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0215(20000815)87:4<606::AID-IJC23>3.0.CO;2-O","article-title":"Efficacy of ionizing radiation combined with adenoviral p53 therapy in EBV-positive nasopharyngeal carcinoma","volume":"87","author":"Li","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.cgt.7700548","article-title":"The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider","volume":"9","author":"Vile","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0042-6822(61)90051-4","article-title":"Biochemical studies on adenovirus multiplication. 2. Kinetics of nucleic acid and protein synthesis in suspension cultures","volume":"13","author":"Green","year":"1961","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1172\/JCI9180","article-title":"Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen","volume":"106","author":"Kurihara","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.gt.3301402","article-title":"Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis","volume":"8","author":"Ganly","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB24","first-page":"1193","article-title":"In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy","volume":"60","author":"Rogulski","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB25","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1128\/JVI.72.12.9479-9490.1998","article-title":"p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection","volume":"72","author":"Goodrum","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB26","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","article-title":"Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells","volume":"72","author":"Rothmann","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","article-title":"Adenovirus proteins from both E1b reading frames are required for transformation of rodent cells by viral infection and DNA transfection","volume":"156","author":"Barker","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0042-6822(90)90088-9","article-title":"Interaction of adenoviral E4 and E1b products in late gene expression","volume":"174","author":"Bridge","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1101\/gad.7.4.546","article-title":"Wild-type p53 mediates apoptosis by E1a, which is inhibited by E1b","volume":"7","author":"Debbas","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB30","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.89.16.7742","article-title":"The adenovirus E1a proteins induce apoptosis, which is inhibited by the E1b 19-kDa and Bcl-2 proteins","volume":"89","author":"Rao","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1101\/gad.8.2.190","article-title":"Adenovirus E1b oncoprotein tethers a transcriptional repression domain to p53","volume":"8","author":"Yew","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of Bcl-2 expression by Epstein\u2013Barr-virus latent membrane protein-1 protects infected B-cells from programmed cell-death","volume":"65","author":"Henderson","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB33","first-page":"5736","article-title":"Potential of the conditionally replicative adenovirus Ad5-Delta 24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy","volume":"62","author":"Lamfers","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1520-6823(1999)7:5<261::AID-ROI1>3.0.CO;2-V","article-title":"Strategies for enhancing viral-based gene therapy using ionizing radiation","volume":"7","author":"Chmura","year":"1999","journal-title":"Radiat. Oncol. Invest."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB35","doi-asserted-by":"crossref","first-page":"21495","DOI":"10.1074\/jbc.274.31.21495","article-title":"E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of I kappa B kinases and nuclear factor kappa B activities","volume":"274","author":"Shao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB36","first-page":"178","article-title":"Radiation sensitization of HER-2\/NEU overexpressing head and neck cancer by E1A gene therapy","volume":"221","author":"Chang","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB37","doi-asserted-by":"crossref","first-page":"32739","DOI":"10.1074\/jbc.272.52.32739","article-title":"Inhibition of nuclear factor-kappa B activity is involved in E1A-mediated sensitization of radiation-induced apoptosis","volume":"272","author":"Shao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB38","first-page":"7413","article-title":"E1A inhibition of radiation-induced NF-kappa B activity through suppression of IKK activity and I kappa B degradation, independent of Akt activation","volume":"61","author":"Shao","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI11918","article-title":"Hostile takeovers: viral appropriation of the NF-kappa B pathway","volume":"107","author":"Hiscott","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/mthe.2000.0037","article-title":"Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse","volume":"3","author":"Paielli","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB41","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1128\/JVI.71.11.8902-8907.1997","article-title":"Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication","volume":"71","author":"Nelson","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/104303401750270977","article-title":"Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved\u2014deletion of the viral E1b-19-kD gene increases the viral oncolytic effect","volume":"12","author":"Harrison","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(97)00027-6","article-title":"Delivery of molecular and cellular medicine to solid tumors","volume":"26","author":"Jain","year":"1997","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB44","first-page":"161","article-title":"The interaction between host-supplied connective-tissue and xenografted human tumor-cells","volume":"10","author":"Kopfmaier","year":"1990","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB45","first-page":"211","article-title":"Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids","volume":"Vol. 64","author":"Durand","year":"2001"},{"key":"10.1016\/j.ymthe.2004.03.016_BIB46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/10430340152712656","article-title":"Subcutaneous administration of a replication-competent adenovirus expressing HSV-tk to cotton rats: dissemination, persistence, shedding, and pathogenicity","volume":"13","author":"Wildner","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB47","first-page":"798","article-title":"A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer","volume":"6","author":"Ganly","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2004.03.016_BIB48","first-page":"4968","article-title":"Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer","volume":"62","author":"Freytag","year":"2002","journal-title":"Cancer Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:19:36Z","timestamp":1585786776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1525001604001121"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.03.016","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}